MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1-论文-万方医学网

MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1

导出原文传递

翻译打印收藏纠错

作者： Al-Showimi, Maram ^[1] ; Al-Yousef, Nujoud ; Alharbi, Wejdan ; Alkhezayem, Sara ; Almalik, Osama ; Alhusaini, Hamed ; Alghamdi, Amani ; Al-Moghrabi, Nisreen

作者单位： Dept Mol Oncol,King Faisal Specialist Hosp & Res Ctr ^[1]

关键词 BRCA1 methylation WBC miR-126 breast cancer ovarian cancer PROMOTER METHYLATION SPORADIC BREAST EPIGENETIC INACTIVATION ABERRANT EXPRESSION MIR-126 DNA HYPERMETHYLATION MUTATIONS PATHOLOGY

发布时间 2024-04-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1

相似文献

相关期刊

检索历史清除